Comparative Risk of Renal Adverse Events in Patients Receiving Immune Checkpoint Inhibitors: A Bayesian Network Meta-Analysis

BACKGROUND: Immune checkpoint inhibitors (ICIs) have brought a paradigm shift to cancer treatment. However, little is known about the risk of renal adverse events (RAEs) of ICI-based regimens, especially ICI combination therapy. METHODS: We carried out a network meta-analysis of randomized controlle...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Kang, Qin, Zhongke, Xu, Xueqiang, Li, Ting, Ge, Yifei, Mao, Huijuan, Xing, Changying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242344/
https://www.ncbi.nlm.nih.gov/pubmed/34221977
http://dx.doi.org/10.3389/fonc.2021.662731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242344/
https://www.ncbi.nlm.nih.gov/pubmed/34221977
http://dx.doi.org/10.3389/fonc.2021.662731

Ejemplares similares